| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/24/2011 | US20110287040 Materials and methods for treatment of inflammation |
| 11/24/2011 | US20110287039 Expression system for modulating an immune response |
| 11/24/2011 | US20110287038 Method for treating solid tumors |
| 11/24/2011 | US20110287037 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof |
| 11/24/2011 | US20110287036 Novel cancer targeting therapy using complex of subtance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound |
| 11/24/2011 | US20110287034 Therapeutic and diagnostic methods relating to cancer stem cells |
| 11/24/2011 | US20110287032 Novel ctla4-ig immunoadhesins |
| 11/24/2011 | US20110287031 Covalently reactive transition state analogs and methods of use thereof |
| 11/24/2011 | US20110287030 Compositions and methods for diagnosing and treating an inflammation |
| 11/24/2011 | US20110287029 Inhibition of the beta3 subunit of l-type ca2+ channels |
| 11/24/2011 | US20110287028 Methods of Treatment Using Human Anti-IL-23 Antibodies |
| 11/24/2011 | US20110287027 Pain treatment |
| 11/24/2011 | US20110287026 Sirt4 and uses thereof |
| 11/24/2011 | US20110287025 Combination therapy and method for assessing resistance to treatment |
| 11/24/2011 | US20110287024 Vascular endothelial cell growth factor antagonists |
| 11/24/2011 | US20110287023 High Affinity Antibodies Against HMGB1 and Methods of Use Thereof |
| 11/24/2011 | US20110287022 Interferon alpha-induced pharmacodynamic markers |
| 11/24/2011 | US20110287021 Neoplasm specific antibodies and uses thereof |
| 11/24/2011 | US20110287020 Recombinant vectors |
| 11/24/2011 | US20110287019 Therapeutic targeting of escort proteins |
| 11/24/2011 | US20110287018 Methods of Treating Interstitial Cystitis |
| 11/24/2011 | US20110287017 Anti-p-selectin antibodies and methods of their use and identification |
| 11/24/2011 | US20110287016 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 11/24/2011 | US20110287015 Mg53 compositions and methods of use |
| 11/24/2011 | US20110287014 Antibodies directed against calcium channel subunit alpha2/delta and methods using same |
| 11/24/2011 | US20110287013 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 11/24/2011 | US20110287012 Nucleic acid encoding cytokine receptor zcytor17 |
| 11/24/2011 | US20110287011 DDR1-Binding Agents and Methods of Use Thereof |
| 11/24/2011 | US20110287010 Diagnostic methods and markers |
| 11/24/2011 | US20110287009 Production of Heteromultimeric Proteins |
| 11/24/2011 | US20110287008 Inhibition of emmprin to treat multiple sclerosis |
| 11/24/2011 | US20110287007 Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6 |
| 11/24/2011 | US20110287006 Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent |
| 11/24/2011 | US20110287005 Monoclonal antibodies against amyloid beta protein and uses thereof |
| 11/24/2011 | US20110287004 Mg53 compositions and methods of use |
| 11/24/2011 | US20110287003 Treatment methods |
| 11/24/2011 | US20110287002 Antibodies against epidermal growth factor receptor (egfr) and uses thereof |
| 11/24/2011 | US20110287001 Method of treatment |
| 11/24/2011 | US20110287000 Treatment of autoimmune and inflammatory disease |
| 11/24/2011 | US20110286999 Methods for reversing multiple resistance in animal cells |
| 11/24/2011 | US20110286998 Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors |
| 11/24/2011 | US20110286997 Genetic Alterations on Chromosome 16 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes |
| 11/24/2011 | US20110286965 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 11/24/2011 | US20110286964 Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 11/24/2011 | US20110286963 Human soluble cd146, preparation and uses thereof |
| 11/24/2011 | US20110286937 Synthetic glycolipid-containing liposome |
| 11/24/2011 | US20110286935 Multi-Functional Nano-Device |
| 11/24/2011 | US20110286932 Optical method for the detection of alzheimer's disease |
| 11/24/2011 | US20110286926 Degradable hydrogel compositions and methods |
| 11/24/2011 | US20110286924 Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancer |
| 11/24/2011 | US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 11/24/2011 | US20110286917 Novel, Prostate-Specific Gene for Diagnosis, Prognosis and Management of Prostate Cancer |
| 11/24/2011 | US20110286916 Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use |
| 11/24/2011 | CA2837059A1 Cancer treatment |
| 11/24/2011 | CA2801897A1 Marker vaccine for classical swine fever |
| 11/24/2011 | CA2800150A1 Influenza virus reassortment method |
| 11/24/2011 | CA2800139A1 Mycobacterial antigen composition |
| 11/24/2011 | CA2799767A1 Latent human immunodeficiency virus reactivation |
| 11/24/2011 | CA2799732A1 Methods relating to an attenuated mycoplasma |
| 11/24/2011 | CA2799480A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases |
| 11/24/2011 | CA2799202A1 Compositions and methods for treatment of autoimmune and other diseases |
| 11/24/2011 | CA2798778A1 Anti-human trop-2 antibody having anti-tumor activity in vivo |
| 11/24/2011 | CA2798055A1 Parapoxvirus vectors containing rabies virus antigen |
| 11/24/2011 | CA2791951A1 Biological materials related to her3 |
| 11/23/2011 | EP2388323A2 Humanized anti-9 integrin antibodies and the uses thereof |
| 11/23/2011 | EP2388320A1 Anti-hs6st2 antibody and use thereof |
| 11/23/2011 | EP2388315A2 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 11/23/2011 | EP2388277A2 Human anti-B7RP1 neutralizing antibodies |
| 11/23/2011 | EP2388276A2 Human anti-B7RP1 neutralizing antibodies |
| 11/23/2011 | EP2388275A2 An aglycosylated IgG1 antibody to CD3 |
| 11/23/2011 | EP2388274A1 Methods of purifying anti A Beta antibodies |
| 11/23/2011 | EP2388273A1 Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use |
| 11/23/2011 | EP2388272A1 Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use |
| 11/23/2011 | EP2388270A2 Modulation of SIRPa - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 11/23/2011 | EP2388265A1 Compositions and methods for the treatment of immune related diseases |
| 11/23/2011 | EP2388015A1 DNA expression vectors and methods of use |
| 11/23/2011 | EP2388014A1 Therapeutic application of tumoral immunoglobulin variable region peptides in patients with B-cell malignancies |
| 11/23/2011 | EP2387587A1 Recombinant monovalent antibodies |
| 11/23/2011 | EP2387584A1 Combination antibodies for the treatment and prevention of disease caused by bacillus anthracis and related bacteria and their toxins |
| 11/23/2011 | EP2387418A1 Pain treatment |
| 11/23/2011 | EP2387417A2 Broad spectrum vaccine against non-typhoidal salmonella |
| 11/23/2011 | EP2387416A1 Purified plasmodium and vaccine compositions |
| 11/23/2011 | EP2387415A1 Vaccine compositions |
| 11/23/2011 | EP2387414A1 Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation |
| 11/23/2011 | EP2387412A1 Methods for increasing adiponectin |
| 11/23/2011 | EP2061907B1 Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181 |
| 11/23/2011 | EP1991563B1 Peptide sequences and compositions |
| 11/23/2011 | EP1784426B1 Humanized anti-beta7 antagonists and uses therefor |
| 11/23/2011 | EP1765328B1 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody |
| 11/23/2011 | EP1720909B1 Anti-abeta antibody |
| 11/23/2011 | EP1678305B1 Protozoan strain of the species leishmania infantum of reduced virulence and use thereof |
| 11/23/2011 | EP1608683B1 Antibodies directed against hepatitis c virus e1e2 complex and pharmaceutical compositions |
| 11/23/2011 | EP1511772B1 Method for obtaining anti-idiotype antibodies |
| 11/23/2011 | EP1362105B1 Anti-interferon-alpha antibodies |
| 11/23/2011 | EP1297109B1 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same |
| 11/23/2011 | EP1296715B1 Multivalent vaccine composition |
| 11/23/2011 | CN1902229B IL-18 binding proteins |
| 11/23/2011 | CN102257138A Tumor antigen peptide and use thereof |
| 11/23/2011 | CN102257135A Production of viral vaccine |
| 11/23/2011 | CN102257127A Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon |